Cubist Pharmaceuticals completes acquisition of Adolor Corporation
Cubist Pharmaceuticals, Inc. today announced that it has completed the previously announced acquisition of Adolor Corporation for an aggregate upfront cash consideration of approximately $221 million.
Chemical company The Dow Chemical Company said on Monday that it has completed the sale of its acrylic acid, esters and speciality latex assets in North America to French chemicals manufacturer Arkema.